Tech • IA • Crypto
50 articles analyzed by AI / 95 total
A DeepMind spinoff has developed AI-designed drugs that are now advancing into human clinical trials as of April 2026. This breakthrough signals a major advancement in AI-driven medicine, potentially accelerating the drug discovery process significantly.
The Utah medical board called for the immediate suspension of the state’s AI doctor experiment in April 2026, citing concerns over patient safety and regulatory compliance. This highlights growing scrutiny around AI’s role in direct clinical care.
APOLLO AI has been trained on 25 billion medical events to enhance disease prediction capabilities, marking a significant step in AI-powered healthcare analytics as of April 2026. This large-scale data training aims to improve future disease forecasting.
A recent survey reported in April 2026 found that one in three Americans believe AI diagnosed health problems that their doctors missed. This underscores the growing reliance on AI technologies for medical diagnostics among the U.S. population.
Hippocratic AI expanded its partnerships with leading health systems in April 2026 to improve patient outcomes through AI-driven solutions. These collaborations aim to integrate AI tools for enhanced healthcare delivery.
In April 2026, CVS Health and Google Cloud launched the Health100 AI platform aimed at enhancing healthcare data analysis and patient care starting in 2024. This platform represents a major initiative to leverage cloud and AI technologies in healthcare.
Researchers from City of Hope and UC Berkeley developed an AI technique to analyze individual breast cells for identifying cancer risk, enhancing early detection as of April 2026. This technology promises improvements in personalized cancer diagnostics.
OpenAI introduced a specialized ChatGPT version for clinicians in April 2026 to improve medical assistance and clinical decision-making. This represents a targeted effort to harness conversational AI for healthcare professionals.
A study published in April 2026 found that AI analysis of eye photographs could provide early warnings for chronic health problems. This development highlights non-invasive diagnostics as a promising direction for disease detection.
Machine learning combined with biomarkers is being used to predict Parkinson’s disease, potentially improving early diagnosis and treatment outcomes as reported in April 2026. This represents progress in neurological disease management using AI.